JOSEPH HILL iii

H.R. 6992, S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 8333 - BIOSECURE Act: Provisions related to pharmaceutical supply chain and drug shortages.

H.R. 6992, S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions related to supply chain risk assessment and supply chain shortages. National Defense Authorization Act; Labor, Health and Human Services and related agencies Appropriations: Provisions related to pharmaceutical supply chain and quality. Issues related to drug shortages.

H.R. 6992, S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions related to supply chain risk assessment and supply chain shortages.

S. 5243: Cannabinoid Safety and Regulation Act - Provisions related to role of quality standards in potential cannabis regulation. Issues related to pharmaceutical supply chain and drug shortages.

S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions related to supply chain risk assessment. The Pandemic and All-Hazards Preparedness Reauthorization Act: Provisions related to a more resilient pharmaceutical supply chain. Issues related to the Food and Drug Administration's Regulation of cannabidiol products.

S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions related to supply chain risk assessment. The Pandemic and All-Hazards Preparedness Reauthorization Act: Provisions related to a more resilient pharmaceutical supply chain.

S. 3799 - PREVENT Pandemics Act: Issues related to health care supply-chain. H.R. 2471 - FY22 Consolidated Appropriations Act: Provisions related to FDA funding.

H.R. 4521 - America COMPETES Act: Provisions related to advanced pharmaceutical manufacturing and pharmaceutical supply chain resiliency. H.R. 2471 - FY22 Consolidated Appropriations Act, H.R. 7667 - Food and Drug Amendments of 2022, Prescription Drug User Fee Reauthorization: Provisions related to FDA funding. S. 4090 - Dietary Supplement Listing Act of 2022: Provisions related to mandatory product listing for dietary supplements.

H.R. 2617: The Consolidated Appropriations Act of 2023 - Provisions related to pharmaceutical supply chain resiliency and national centers of excellence in advanced pharmaceutical manufacturing.

H.R. 4521 - America COMPETES Act: Provisions related to advanced pharmaceutical manufacturing and pharmaceutical supply chain resiliency. Fiscal Year 2023 Consolidated Appropriations Act; H.R. 7667 - Food and Drug Amendments of 2022: Provisions related to the Prescription Drug User Fee Reauthorization and FDA funding. S. 4090 - Dietary Supplement Listing Act of 2022: Provisions related to mandatory product listing for dietary supplements.

H.R. 4521 - America COMPETES Act: Provisions related to advanced pharmaceutical manufacturing and pharmaceutical supply chain resiliency. H.R. 2471 - FY22 Consolidated Appropriations Act, H.R. 7667 - Food and Drug Amendments of 2022, Prescription Drug User Fee Reauthorization: Provisions related to FDA funding. S. 4090 - Dietary Supplement Listing Act of 2022: Provisions related to mandatory product listing for dietary supplements.

H.R. 4521 - America COMPETES Act: Provisions related to advanced pharmaceutical manufacturing and pharmaceutical supply chain resiliency. Fiscal Year 2023 Consolidated Appropriations Act; H.R. 7667 - Food and Drug Amendments of 2022: Provisions related to the Prescription Drug User Fee Reauthorization and FDA funding. S. 4090 - Dietary Supplement Listing Act of 2022: Provisions related to mandatory product listing for dietary supplements.

H.R. 4521 - America COMPETES Act: Provisions related to advanced pharmaceutical manufacturing and pharmaceutical supply chain resiliency. H.R. 2471 - FY22 Consolidated Appropriations Act, H.R. 7667 - Food and Drug Amendments of 2022, Prescription Drug User Fee Reauthorization: Provisions related to FDA funding. S. 4090 - Dietary Supplement Listing Act of 2022: Provisions related to mandatory product listing for dietary supplements.

S. 3799 - PREVENT Pandemics Act: Issues related to health care supply-chain. H.R. 2471 - FY22 Consolidated Appropriations Act: Provisions related to FDA funding.

H.R. 4521 - America COMPETES Act: Provisions related to advanced pharmaceutical manufacturing and pharmaceutical supply chain resiliency. Fiscal Year 2023 Consolidated Appropriations Act; H.R. 7667 - Food and Drug Amendments of 2022: Provisions related to the Prescription Drug User Fee Reauthorization and FDA funding. S. 4090 - Dietary Supplement Listing Act of 2022: Provisions related to mandatory product listing for dietary supplements.

H.R. 4521 - America COMPETES Act: Provisions related to advanced pharmaceutical manufacturing and pharmaceutical supply chain resiliency. H.R. 2471 - FY22 Consolidated Appropriations Act, H.R. 7667 - Food and Drug Amendments of 2022, Prescription Drug User Fee Reauthorization: Provisions related to FDA funding. S. 4090 - Dietary Supplement Listing Act of 2022: Provisions related to mandatory product listing for dietary supplements.

S. 2595 - Drug Shortages Prevention and Quality Improvement Act: Provisions related to the advance manufacturing grant program. 21st Century Cures Act 2.0, discussion draft: Provisions related to Compounding and Drug Pricing. American Rescue Plan Act (P.L. 117-2): Provisions related to implementation of supply chain reform and COVID-19 pandemic response. FY 2022 Appropriations: Provisions related to Cannabis and Infrastructure and budget reconciliation legislation. Cannabis Opportunity and Administration, discussion draft: Provisions related to quality standards for cannabis and hemp.

Pub.L. 116-136; CARES Act; implementation as it relates to supporting public health infrastructure. HR 4866; National Centers of Excellence in Continuous Manufacturing act; all provisions. S. 3432; Securing America's Medicine Cabinet Act; all provisions.

HR 748, CARES Act; provisions related to supply-chain and drug shortages. Support for additional FY2021 funding for the Food and Drug Administration (FDA).

Pub.L. 116-136; CARES Act; implementation as it relates to supporting public health infrastructure. HR 4866; National Centers of Excellence in Continuous Manufacturing act; all provisions. S. 3432; Securing America's Medicine Cabinet Act; all provisions.

S. 3432, Securing America's Medicine Cabinet; provisions related to funding levels for continuous manufacturing centers of excellence S. 3829, Global Health Security Act; provisions that foster international cooperation on matters relating to public health

S. 3829, Global Health Security Act; provisions that foster international cooperation on matters relating to public health

S. 3432, Securing America's Medicine Cabinet; provisions related to funding levels for continuous manufacturing centers of excellence S. 3829, Global Health Security Act; provisions that foster international cooperation on matters relating to public health

HR 1959, To amend the Federal Food, Drug, and Cosmetic Act with respect to compounding pharmacies, and for other purposes; all provisions

H.R.3164 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020; provisions related to encouraging Biosimilar Development S. 1895 Lower Health Care Costs Act; Section 207

S. 1895, Lower Health Care Costs Act; Section 207 Cures 2.0 H.R. 4866, Continuous Pharmaceutical Manufacturing

H.R.3164 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020; provisions related to encouraging Biosimilar Development S. 1895 Lower Health Care Costs Act; Section 207

S. 1895, Lower Health Care Costs Act; Section 207 Cures 2.0 H.R. 4866, Continuous Pharmaceutical Manufacturing

S. 1895 Lower Health Care Costs Act; Section 207 CBD Drug shortages